Early post-marketing experience with edaravone in an unselected group of patients with ALS

.

Source: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration - February 20, 2019 Category: Neurology Authors: Alon Abraham Beatrice Nefussy Yaara Fainmesser Yoram Ebrahimi Arnon Karni Vivian E. Drory Source Type: research